Feed NOTV
NO

Inotiv, Inc. NOTV · NASDAQ

$0.08 -3.73% (-$0.00)

Market cap
$2.79M
Enterprise value
$404.3M
P/E
-
Forward P/E
-
PEG
-
P/S
0.0x
P/FCF
-
EV/EBITDA
7.9x
ROIC
-1.8%
Gross margin
10.4%
Net margin
-17.7%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
7.8x
Beta
4.08
Free float
92.6%

About the company

Inotiv, Inc. (NOTV) is an American company specializing in providing preclinical and clinical laboratory services for the pharmaceutical and biotechnology industries. With a wide range of analytical and developmental services, Inotiv contributes to the research of new drugs and ensures quality testing for clients worldwide. The company is known for its expertise, technological capabilities, and the ability to quickly respond to the dynamic needs of the biotechnology and pharmaceutical environment. Shares of Inotiv, Inc. (NOTV) could be suitable for investors seeking opportunities in the growing field of preclinical and clinical research with an emphasis on quality and innovation.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Robert W. Leasure

Employees

2,027

Headquarters

West Lafayette

Valuation

Is today's price reasonable?

  • What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Revenue grew by 112% a year over the last 3 years.
  • What to watch: It missed profit estimates 4 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: Repaying its net debt would take 7.8 years of operating profit.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy